Fusion Pharmaceuticals Inc. Annual Revenues in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Revenues history and growth rate from 2021 to 2023.
  • Fusion Pharmaceuticals Inc. Revenues for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Fusion Pharmaceuticals Inc. Revenues for the twelve months ending December 31, 2023 was $2.07M, a 41.5% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Revenues for 2023 was $2.07M, a 41.5% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Revenues for 2022 was $1.46M, a 1.46% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.07M +$607K +41.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $1.46M +$21K +1.46% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $1.44M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.